Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Gettysburg › NPI 1265466957
Clinic

The Gettysburg Hospital

The Gettysburg Hospital was paid $7.62M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.

33Billing provider infoTHE GETTYSBURG HOSPITAL
GETTYSBURG, PA 17325
33aNPI1265466957assigned 07/10/2006
33bProvider typeClinic/Center
28Total paid$7.62M
24GClaims229,887
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinic/Center providers in Pennsylvania

Rank by total paid#23 of 176
Median peer was paid$441K
This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018708$54K
20191,135$36K
202025,440$664K
2021118,973$3.34M
202231,228$1.24M
202332,670$1.40M
2024incomplete19,733$900K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 23% 9,652 8,831 $1.73M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 8,240 7,847 $1.17M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 6,370 5,910 $927K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 9.7% 8,471 7,944 $737K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 3.3% 5,973 1,961 $251K
0202U Oncology (prostate), multianalyte, gene expression profiling 2.3% 1,321 1,284 $175K
80053 Comprehensive metabolic panel 1.6% 14,534 13,521 $125K
G0378 Hospital observation service, per hour 1.4% 134 130 $109K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.4% 3,665 3,587 $104K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 645 624 $90K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.2% 4,553 4,283 $90K
80050 General health panel 1.1% 1,776 1,746 $87K
241 more codes
77067 Screening mammography, bilateral, including computer-aided detection 1.0% 888 $77K
36415 Collection of venous blood by venipuncture <1% 24,567 $76K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,804 $73K
80061 Lipid panel <1% 4,699 $68K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 740 $65K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,496 $59K
81513 <1% 494 $56K
84443 Thyroid stimulating hormone (TSH) <1% 2,259 $52K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,146 $52K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 168 $43K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 903 $42K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 709 $37K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 809 $34K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,723 $32K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,571 $31K
96375 Therapeutic injection; each additional sequential IV push <1% 2,395 $31K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 604 $29K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 4,137 $29K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 180 $28K
84702 <1% 2,228 $27K
71275 Computed tomographic angiography, chest, with contrast material <1% 207 $27K
96361 Intravenous infusion, hydration; each additional hour <1% 2,820 $26K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 262 $25K
83036 Hemoglobin; glycosylated (A1C) <1% 3,082 $22K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 333 $22K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 757 $21K
76830 Ultrasound, transvaginal <1% 440 $21K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 283 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 798 $20K
77063 Screening digital breast tomosynthesis, bilateral <1% 869 $20K
97161 <1% 362 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 451 $20K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 343 $19K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 635 $19K
84466 <1% 1,075 $18K
70450 Computed tomography, head or brain; without contrast material <1% 391 $17K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 247 $17K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 767 $17K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 491 $16K
80048 Basic metabolic panel (calcium, ionized) <1% 2,122 $16K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,855 $14K
87481 <1% 183 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,796 $14K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 130 $13K
81001 <1% 6,118 $13K
82607 <1% 1,017 $13K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 486 $12K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 50 $12K
95886 <1% 262 $12K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 209 $12K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 73 $12K
83735 <1% 2,251 $12K
71046 Radiologic examination, chest; 2 views <1% 956 $11K
86803 <1% 545 $11K
83880 <1% 478 $11K
84484 <1% 1,587 $11K
93971 <1% 186 $11K
76536 <1% 210 $10K
97162 <1% 188 $10K
84146 <1% 379 $10K
80081 <1% 111 $10K
84439 <1% 1,150 $10K
83540 <1% 1,137 $9K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 169 $9K
82728 <1% 788 $9K
71250 <1% 143 $9K
76642 <1% 209 $9K
76801 <1% 234 $9K
72100 <1% 513 $9K
76819 Fetal biophysical profile; without non-stress testing <1% 164 $8K
85027 <1% 1,239 $8K
93976 <1% 111 $8K
87653 <1% 189 $8K
86618 <1% 311 $8K
J1756 Injection, iron sucrose, 1 mg <1% 154 $8K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 382 $7K
96376 <1% 268 $7K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12 $7K
93017 <1% 191 $7K
83690 <1% 1,845 $7K
73564 <1% 314 $6K
84403 <1% 209 $6K
83516 <1% 279 $6K
77066 Tomosynthesis, mammo <1% 74 $6K
82570 <1% 823 $6K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 676 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 176 $5K
83970 <1% 138 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 715 $5K
87799 <1% 60 $5K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 95 $5K
94729 <1% 174 $5K
85610 <1% 1,510 $5K
82043 <1% 555 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 57 $5K
71045 Radiologic examination, chest; single view <1% 783 $5K
73030 <1% 307 $4K
82784 <1% 231 $4K
72110 <1% 203 $4K
73221 <1% 14 $4K
87493 <1% 101 $4K
84402 <1% 138 $4K
87077 <1% 588 $4K
73610 <1% 235 $4K
86038 <1% 246 $4K
87340 <1% 263 $4K
82105 <1% 185 $4K
87186 <1% 495 $4K
86850 <1% 480 $4K
76770 <1% 82 $4K
73630 <1% 327 $4K
82746 <1% 317 $4K
72141 <1% 12 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 364 $3K
95910 <1% 59 $3K
85379 <1% 493 $3K
73502 <1% 183 $3K
87522 Neg quan hep c or qual rna <1% 71 $3K
77065 Tomosynthesis, mammo <1% 44 $3K
70496 <1% 27 $3K
87040 <1% 222 $3K
95800 <1% 24 $3K
80076 <1% 296 $3K
82248 <1% 458 $3K
82550 <1% 465 $3K
84100 <1% 449 $3K
73130 <1% 238 $3K
84153 <1% 112 $3K
72050 <1% 104 $3K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 114 $2K
85730 <1% 524 $2K
83605 <1% 445 $2K
85652 <1% 782 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 52 $2K
72040 <1% 142 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 54 $2K
94726 <1% 77 $2K
86140 <1% 696 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 63 $2K
86765 <1% 150 $2K
70498 <1% 15 $2K
74018 <1% 168 $2K
82565 <1% 342 $2K
94060 <1% 176 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 959 $2K
87512 <1% 65 $2K
82947 <1% 806 $2K
73562 <1% 126 $2K
86592 <1% 407 $2K
83001 <1% 87 $2K
83721 <1% 136 $2K
77062 <1% 65 $1K
76981 <1% 24 $1K
82950 <1% 190 $1K
87209 <1% 59 $1K
86901 <1% 379 $1K
86900 <1% 379 $1K
84550 <1% 181 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 27 $1K
82977 <1% 108 $1K
84156 <1% 244 $1K
87427 <1% 70 $945.46
96367 <1% 66 $910.92
97014 <1% 43 $881.94
83615 <1% 113 $840.24
82150 <1% 153 $823.03
93970 <1% 13 $816.53
95911 <1% 14 $811.22
84704 <1% 48 $809.37
84163 <1% 46 $772.87
86376 <1% 86 $751.23
80074 <1% 12 $726.74
83002 <1% 38 $722.63
87081 <1% 133 $712.92
J1170 Injection, hydromorphone, up to 4 mg <1% 440 $694.86
80069 <1% 76 $693.59
84481 <1% 27 $683.53
90715 <1% 44 $663.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,289 $617.34
83993 <1% 27 $608.98
86431 <1% 76 $605.56
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,188 $603.47
87328 <1% 39 $576.40
83921 <1% 30 $556.30
87045 <1% 70 $535.74
97164 <1% 15 $528.38
87329 <1% 39 $515.30
87177 <1% 59 $484.01
81025 <1% 147 $459.60
83655 <1% 39 $458.50
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,498 $447.37
86706 <1% 36 $443.67
J7030 Infusion, normal saline solution , 1000 cc <1% 876 $428.93
82247 <1% 65 $395.90
81003 <1% 115 $380.85
87046 <1% 70 $362.71
84520 <1% 97 $339.78
94760 <1% 18 $324.51
82627 <1% 14 $322.56
J2704 Injection, propofol, 10 mg <1% 964 $313.63
83525 <1% 29 $297.55
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,251 $293.86
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) <1% 101 $278.64
87015 <1% 39 $276.54
94727 <1% 14 $233.66
73590 <1% 12 $219.98
J0780 Injection, prochlorperazine, up to 10 mg <1% 335 $216.97
84460 <1% 27 $184.32
86039 <1% 12 $174.75
84450 <1% 27 $173.60
80055 <1% 13 $168.60
83520 <1% 12 $159.56
82533 <1% 13 $156.41
72072 <1% 13 $155.98
82951 <1% 12 $150.67
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 418 $140.97
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,086 $138.07
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 815 $124.71
87205 <1% 29 $112.92
86308 <1% 15 $104.77
88304 <1% 27 $101.52
87070 <1% 12 $89.73
82040 <1% 27 $82.40
76882 <1% 14 $73.99
J3475 Injection, magnesium sulfate, per 500 mg <1% 170 $67.11
80051 <1% 13 $66.51
82310 <1% 13 $61.00
J2060 Injection, lorazepam, 2 mg <1% 180 $48.39
J0690 Injection, cefazolin sodium, 500 mg <1% 105 $45.56
87147 <1% 14 $43.12
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 451 $37.14
A9270 Non-covered item or service <1% 75 $35.52
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 148 $13.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 77 $11.38
J8597 Antiemetic drug, oral, not otherwise specified <1% 30 $5.91
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 20 $2.70
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 305 $0.02
J1171 Injection, hydromorphone, 0.1 mg 0% 18 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 309 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 18 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOGLIANO, MICHAEL (VP OPERATIONS)
Same official

Other billing entities under COGLIANO, MICHAEL

Full network →
ProviderLocationPaid
The Gettysburg HospitalGettysburg, PA$1.37M
Washingtonville Central School DistrictCampbell Hall, NY$32K
The Gettysburg HospitalGettysburg, PA$16.93

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.